跳至主要内容
临床试验/NCT03413423
NCT03413423进行中(未招募)不适用

Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management

Hennepin Healthcare Research Institute2 个研究点 分布在 1 个国家目标入组 233 人开始时间: 2018年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
233
试验地点
2
主要终点
Depression Symptoms

研究概览

简要总结

Summary of the Project :

Quitting smoking following acute coronary syndrome (ACS) can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both smoking and depression could be highly effective in reducing post-acute coronary syndrome mortality. Behavioral Activation (BA) is a well established treatment for depression and has recently shown promise as a treatment for smoking cessation. The investigators systematically developed an intervention integrating gold standard smoking cessation counseling with existing BA based mood management techniques for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS).

Objective: For this R01 the investigators will evaluate the efficacy of using a single, integrated treatment that targets both depressed mood and smoking (BAT-CS).

详细描述

This project will implement a fully powered efficacy trial enrolling 324 smokers with ACS and randomize them to 12 weeks of either Behavioral Activation Treatment for Cardiac Smokers (BAT-CS) or control condition (including contact match). BAT-CS interventions will focus on smoking cessation and mood management, while the control condition will focus on smoking cessation and general health education. Both groups will be offered the nicotine patch if medically safe. Follow-up assessments will be conducted at end-of-treatment (12 weeks post-discharge for index event), and 6, 9, and 12 months after hospital discharge. The occurrence of major adverse cardiac events and all-cause mortality will be tracked for up to 60 months post discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hospital inpatients with an ACS diagnosis documented in medical record within the past 30 days
  • smoked equal or greater than 1 cigarette per day before being hospitalized
  • age of 18-75 years
  • English fluency
  • willing to consider quitting smoking at discharge
  • has a telephone or is willing to use a study issued cell phone
  • willing to consent to all study procedures.

排除标准

  • limited mental competency
  • presence of severe mental illness that would interfere with participation or suicidality
  • expected discharge to hospice or greater than 50% chance of 6 month mortality per risk calculator
  • currently attending counseling for depression or smoking cessation.

结局指标

主要结局

Depression Symptoms

时间窗: 12 Months

The 9 item Patient Health Questionnaire (PHQ-9) ranges from 0-27 with higher scores indicating higher depression symptoms.

7-day point prevalence abstinence from smoking

时间窗: 12 Months

Self-report of no smoking, not even a puff, for 7 days; then Bio-chemically confirmed with saliva cotinine or by carbon monoxide in a breath sample

次要结局

  • Depressed mood(The 10 item Center for Epidemiologic Studies Depression Scale ranges from 0-30 with higher scores indicating higher depression symptoms.)
  • Positive Affect(12 Months)
  • Continuous Abstinence From Smoking Since Hospital Discharge(12 Months)
  • Health Related Quality of Life(12 Months)
  • Time to Smoking Lapse(12 Months)
  • Major adverse cardiac events (MACE) and all cause mortality(5 years)
  • Time to Smoking Relapse(12 Months)
  • Negative Affect(12 Months)
  • Systolic and Diastolic Blood Pressure(12 Months)
  • Blood Bio-markers(12 Months)
  • Treatment Acceptability(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Busch

Senior Investigator

Hennepin Healthcare Research Institute

研究点 (2)

Loading locations...

相似试验